For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.
The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback